Page last updated: 2024-09-03

omega-n-methylarginine and mozavaptan

omega-n-methylarginine has been researched along with mozavaptan in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010) (mozavaptan)
4,411344336165824

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)mozavaptan (IC50)
Vasopressin V2 receptorHomo sapiens (human)0.6373
Vasopressin V1a receptorRattus norvegicus (Norway rat)3.2
Vasopressin V1a receptorHomo sapiens (human)1.1373
Vasopressin V1b receptorHomo sapiens (human)2
Vasopressin V1b receptorRattus norvegicus (Norway rat)5
Vasopressin V2 receptor Rattus norvegicus (Norway rat)0.012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A1

Other Studies

1 other study(ies) available for omega-n-methylarginine and mozavaptan

ArticleYear
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents

1997